Jove
Visualize
Contact Us

Related Concept Videos

Cancer Survival Analysis01:21

Cancer Survival Analysis

345
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
345
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
  1. Home
  3. Prevalence And Predictive Value Of Sarcopenia In Surgically Treated Cholangiocarcinoma: A Comprehensive Review And Meta-analysis.
  1. Home
  3. Prevalence And Predictive Value Of Sarcopenia In Surgically Treated Cholangiocarcinoma: A Comprehensive Review And Meta-analysis.

Related Experiment Video

Segmentation and Linear Measurement for Body Composition Analysis using Slice-O-Matic and Horos
13:35

Segmentation and Linear Measurement for Body Composition Analysis using Slice-O-Matic and Horos

Published on: March 21, 2021

10.5K

Prevalence and predictive value of sarcopenia in surgically treated cholangiocarcinoma: a comprehensive review and

Jie He1,2, Yuanyuan Huang1,2, Na Huang1,2

  • 1Clinical Medical College of Chengdu Medical College, Chengdu, Sichuan, China.

Frontiers in Oncology
|April 4, 2024

View abstract on PubMed

Summary
This summary is machine-generated.

Sarcopenia, a loss of muscle mass, affects 43% of cholangiocarcinoma patients and is linked to poorer survival and more complications. Early detection and treatment of sarcopenia can improve outcomes for these cancer patients.

Keywords:
cholangiocarcinomameta-analysisprognosissarcopeniaskeletal muscle mass index

More Related Videos

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
06:46

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery

Published on: September 27, 2024

261
Robotic Taj Mahal Hepatectomy for Hilar Cholangiocarcinoma
09:19

Robotic Taj Mahal Hepatectomy for Hilar Cholangiocarcinoma

Published on: July 14, 2022

3.4K

Related Experiment Videos

Segmentation and Linear Measurement for Body Composition Analysis using Slice-O-Matic and Horos
13:35

Segmentation and Linear Measurement for Body Composition Analysis using Slice-O-Matic and Horos

Published on: March 21, 2021

10.5K
Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
06:46

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery

Published on: September 27, 2024

261
Robotic Taj Mahal Hepatectomy for Hilar Cholangiocarcinoma
09:19

Robotic Taj Mahal Hepatectomy for Hilar Cholangiocarcinoma

Published on: July 14, 2022

3.4K

Area of Science:

  • Oncology
  • Geriatrics
  • Metabolic Medicine

Background:

  • Sarcopenia, characterized by reduced skeletal muscle mass and function, is increasingly recognized in elderly cancer patients.
  • It is a potential adverse prognostic factor in malignant tumors, including cholangiocarcinoma.
  • This review examines sarcopenia prevalence and its impact on survival and postoperative complications in cholangiocarcinoma.

Approach:

  • A systematic review and meta-analysis of 33 articles from five databases (EMBASE, PubMed, Web of Science, Cochrane Library, CNKI).
  • Keywords included sarcopenia, cholangiocarcinoma, and prognosis.
  • Study quality was assessed using the Newcastle-Ottawa Scale (NOS).

Key Points:

  • The overall prevalence of sarcopenia in cholangiocarcinoma patients is 43%.
  • Sarcopenia is significantly correlated with poorer overall survival (OS), recurrence-free survival (RFS), and disease-free survival (DFS).
  • Sarcopenia is a negative predictive factor across different ethnicities, diagnostic methods, and tumor locations, and a risk factor for postoperative complications.

    • Conclusions:

    • Sarcopenia is significantly associated with adverse survival outcomes and increased postoperative complications in cholangiocarcinoma.
    • Prompt diagnosis and management of sarcopenia are crucial for improving patient prognosis.
    • Further research and clinical integration of sarcopenia assessment are warranted.